PepGen Corp (PEPG) Total Business Assets

Graphic logo of pepgen.com (PEPG)

PepGen Inc. (PEPG) management is focused on optimizing the delivery of therapies for neuromuscular pathologies and validating the efficacy of its platform. The expansion potential within the Duchenne muscular dystrophy gene therapy segment is immense due to the lack of niche saturation. However, global conflicts could hinder component procurement and patent protection. This chart of total asset market quotes, valued at 121.81, illustrates the developer's financial standing.

PepGen (PEPG): Cumulative Company Assets from 04/28/2023 to 10/29/2026

Analytical breakdowns for pepgen.com (PEPG)

- price and consensus price forecast:
Price Rate Chart PepGen|PEPG - Price Target Chart
- market capitalization data:
Market Capitalization PepGen Inc.|PEPG - Enterprise Value
- book capitalization data:
Net Asset Value per Share PepGen|PEPG - Company Net Assets|Market Capitalization to Book Value Ratio pepgen.com|PEPG - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio PepGen Inc.|PEPG - Long-Term Debt to Equity|Current Liabilities to Capital PepGen|PEPG - Company Debts|Debts to Book Capitalization Ratio PepGen Inc.|PEPG - Company Long-Term Debts|Short-Term Debt PepGen
Fundamental company analysis:PepGen Inc.
Finished products of PepGen Inc.

When selecting stocks with a high margin of safety, analyzing total resources—combining capital and liabilities, which are reverse-calculated here via ROA—is critically important. The resource structure dynamics of PepGen Inc. (PEPG) reflect the specifics of outsourcing: the absence of proprietary manufacturing plants minimizes capital expenditures, transforming this indicator into a tool for monitoring the liquidity and debt load of the scientific team.

Competing companies

BIIB (biogen.com) - Company Balance Sheet Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|HRMY (Harmony Corp) - Company Assets|Aggregate Company Assets Biohaven Ltd. BHVN|Total Asset Value of Company amylyx.com|Trevi Therapeutics, Inc. - Company Total Assets|Company Assets PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Aggregate Company Assets|Total Asset Value of Company CeriBell EEG CBLL|Company Total Assets PRTA|ALEC - Company Balance Sheet Assets|Company Total Assets ANNX|OMER (Omeros) - Company Assets|Aggregate Company Assets Neurogene Corp (NGNE)|Total Business Assets AC Immune Inc (ACIU)|Voyager Therapeutics (VYGR) - Cumulative Company Assets|Aggregate Asset Value neumoratx.com (NMRA)|Company Total Assets SCLX|Tevogen Bio Holdings Inc. - Company Total Asset Base|Alpha Cognition Corp (ACOG) - Aggregate Company Assets|CGTX - Total Business Assets|IKT (Inhibikase Therapeutics) - Company Total Assets|Cumulative Company Assets cassavasciences.com|ASRT: Cumulative Company Assets|Company Total Asset Base COYA|VTGN - Aggregate Company Assets|Total Asset Value of Company ovidrx.com (OVID)|ABOS: Company Total Assets|cervomed.com - Company Assets|Aggregate Company Assets Alterity Therapeutics Ltd|CLNN - Total Asset Value of Company|Company Total Assets JUNS (Jupiter Neurosciences)|RLMD (Relmada Corp) - Company Balance Sheet Assets|Aggregate Company Assets Annovis Bio, Inc. (ANVS)|Total Business Assets Grace Tx|Firefly Neuroscience - Company Total Assets|Company Assets anewmeds.com KLTO|Cumulative Company Assets NRSN (NeuroSense Therapeutics Ltd.)|Reviva Pharmaceuticals, Inc. - Company Total Assets|Aggregate Company Assets MetaVia, Inc. (MTVA)|NRXS: Aggregate Asset Value|Aggregate Company Assets HSDT|PASG (Passage Bio) - Company Assets|Aggregate Company Assets Neuphoria Therapeutics, Inc. NEUP|Total Asset Value of Company Minerva|Athira Pharma, Inc. - Company Total Assets|Company Assets ADXN (addextherapeutics.com)|Alzamend Neuro (ALZN) - Aggregate Company Assets|Total Asset Value of Company Cyclerion Therapeutics Inc. CYCN|Company Total Assets PTIX|KTTA - Company Balance Sheet Assets|Company Total Assets CRGT|ATXI (avenuetx.com) - Company Assets|Aggregate Company Assets BrainStorm Cell Therapeutics (BCLI)|Total Business Assets Cara Therapeutics Inc. (CARA)|Chromocell Therapeutics Corporation (CHRO) - Cumulative Company Assets|Aggregate Asset Value eliemtx.com (ELYM)|Company Total Assets ITCI|longboardpharma.com - Company Total Asset Base|Marinus Pharmaceuticals, Inc. (MRNS) - Aggregate Company Assets|NKGN - Total Business Assets|NRBO (NeuroBo) - Company Total Assets|Cumulative Company Assets Sage Therapeutics Inc|SNPX: Cumulative Company Assets|Company Total Asset Base TRVN|VIGL - Aggregate Company Assets|Total Asset Value of Company anewmeds.com (WENA)|CERE: Company Total Assets